MD371Y - Metodă de tratament al tuberculozei oculare - Google Patents

Metodă de tratament al tuberculozei oculare Download PDF

Info

Publication number
MD371Y
MD371Y MDS20100195A MDS20100195A MD371Y MD 371 Y MD371 Y MD 371Y MD S20100195 A MDS20100195 A MD S20100195A MD S20100195 A MDS20100195 A MD S20100195A MD 371 Y MD371 Y MD 371Y
Authority
MD
Moldova
Prior art keywords
isoniazid
treating
ocular tuberculosis
rifampicin
months
Prior art date
Application number
MDS20100195A
Other languages
English (en)
Moldavian (mo)
Inventor
Elvira Velixar
Nicolae Elascu
Nicolae Elaşcu
Original Assignee
Inst Medico Sanitara Publica Inst Ftiziopneumologie Chiril Draganiuc
Institu & Tcedil Ia Medico Sanitar & Abreve Public & Abreve Inst Ftiziopneumologie Chiril Draganiuc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medico Sanitara Publica Inst Ftiziopneumologie Chiril Draganiuc, Institu & Tcedil Ia Medico Sanitar & Abreve Public & Abreve Inst Ftiziopneumologie Chiril Draganiuc filed Critical Inst Medico Sanitara Publica Inst Ftiziopneumologie Chiril Draganiuc
Priority to MDS20100195A priority Critical patent/MD371Z5/ro
Publication of MD371Y publication Critical patent/MD371Y/ro
Publication of MD371Z publication Critical patent/MD371Z/ro
Publication of MD371Z5 publication Critical patent/MD371Z5/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la oftalmologie şi ftiziatrie şi este destinată pentru tratamentul tuberculozei oculare.Conform invenţiei, metoda revendicată constă în aceea că bilateral în regiunea procesului mastoidian, paralel cu pavilionul urechii, subcutanat se administrează consecutiv un amestec de 0,01…0,02 ml de heparină de 5000 UI/ml şi 2,0 ml de novocaină de 0,5%, apoi 1,0…3,0 ml soluţie de izoniazidă de 10%, peste o zi, 10…15 proceduri, totodată, concomitent per os se administrează mildronat 250 mg de două ori pe zi, izoniazidă 300 mg/kg, rifampicină 600 mg/kg, pirazinamidă 1,5 mg/kg, zilnic, timp de 2 luni, iar în următoarele 4 luni per os se administrează izoniazidă 300 mg/kg şi rifampicină 600 mg/kg, zilnic.
MDS20100195A 2010-11-22 2010-11-22 Metodă de tratament al tuberculozei oculare MD371Z5 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100195A MD371Z5 (ro) 2010-11-22 2010-11-22 Metodă de tratament al tuberculozei oculare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100195A MD371Z5 (ro) 2010-11-22 2010-11-22 Metodă de tratament al tuberculozei oculare

Publications (3)

Publication Number Publication Date
MD371Y true MD371Y (ro) 2011-05-31
MD371Z MD371Z (ro) 2012-04-30
MD371Z5 MD371Z5 (ro) 2012-04-30

Family

ID=45815149

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100195A MD371Z5 (ro) 2010-11-22 2010-11-22 Metodă de tratament al tuberculozei oculare

Country Status (1)

Country Link
MD (1) MD371Z5 (ro)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2107480C1 (ru) * 1996-11-22 1998-03-27 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Способ лечения эндогенных и послеоперационных увеитов
RU2189801C2 (ru) * 2000-10-17 2002-09-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения передних увеитов
RU2290191C2 (ru) * 2004-07-12 2006-12-27 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию (ФГУ ТС "Выборг-3" Росздрава") Способ лечения туберкулезных увеитов
RU2299065C1 (ru) * 2005-11-11 2007-05-20 Федеральное государственое учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Агентства по здравоохранению и социальному развитию" Способ лечения рецидивирующего увеита
RU2318534C2 (ru) * 2006-03-27 2008-03-10 Федеральное государственное учреждение туберкулезный санаторий "Выборг-3" Федерального агентства по здравоохранению и социальному развитию Способ лечения туберкулезных увеитов

Also Published As

Publication number Publication date
MD371Z (ro) 2012-04-30
MD371Z5 (ro) 2012-04-30

Similar Documents

Publication Publication Date Title
MX2023008716A (es) Compuesto de camptotecina, metodo de preparacion del mismo y aplicacion del mismo.
MX2025001995A (es) Compuesto heterociclico, procedimiento para prepararlo y uso farmaceutico del mismo
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
EP4233861A3 (en) Compositions for treatment of essential tremor
MX338554B (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
MY199967A (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors
WO2015095819A3 (en) Cancer treatment using combinations of erk and raf inhibitors
MX2009006526A (es) Metodo para suministrar terapia con pirfenidona a un paciente.
PH12015501373A1 (en) Injectable depot formulation comprising optically active tolvaptan and process of producing the same
WO2019157056A8 (en) Treatment of patients with classic fabry disease
PH12015500653A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
MX2009007723A (es) Medicacion basada en exenatida y dalargina para el tratamiento de diabetes mellitus, su uso y modalidad de tratamiento.
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
AU2012207301A8 (en) Apolipoprotein AIV as an antidiabetic peptide
NZ751972A (en) Treatment of prurigo nodularis
MX2016006256A (es) Tratamiento de glaucoma usando laquinimod.
MD371Y (ro) Metodă de tratament al tuberculozei oculare
EP4327869A3 (en) Methods of treating fabry patients having renal impairment
MX2012005497A (es) Tivozanib y temsirolimus en combinacion.
MY206505A (en) Therapeutic agent for glaucoma comprising fp agonist and -blocker
EA032959B1 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
MX2011007522A (es) Metodos de tratamiento de la infeccion por el virus del dengue mediante vitamina d.
MD520Y (ro) Metodă de tratament postoperatoriu al pacienţilor cu litiază renală

Legal Events

Date Code Title Description
ND4Y Validity of short term patent extended [from 6 to 10 years]

Expiry date: 20201122

KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
NF4Y Restoration of lapsed short term patent
MK4Y Short term patent expired